3,4-Dichloro-5-ethyl-1H-pyrrole-2-carboxylic acid → 2-(4-{[(3,4-Dichloro-5-ethyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-1,3-thiazole-5-carboxamide
반응식
[Cl:1][C:2]1[C:6]([Cl:7])=[C:5]([CH2:8][CH3:9])[NH:4][C:3]=1[C:10]([OH:12])=O.Cl.[NH2:14][CH:15]1[CH2:20][CH2:19][N:18]([C:21]2[S:22][C:23]([C:26]([NH2:28])=[O:27])=[CH:24][N:25]=2)[CH2:17][CH2:16]1>>[Cl:1][C:2]1[C:6]([Cl:7])=[C:5]([CH2:8][CH3:9])[NH:4][C:3]=1[C:10]([NH:14][CH:15]1[CH2:20][CH2:19][N:18]([C:21]2[S:22][C:23]([C:26]([NH2:28])=[O:27])=[CH:24][N:25]=2)[CH2:17][CH2:16]1)=[O:12]참가 물질
3
실험 절차
Title compound was synthesized by an analogous method to Example 29 by coupling 3,4-dichloro-5-ethyl-1H-pyrrole-2-carboxylic acid (Intermediate 73) with 2-(4-aminopiperidin-1-yl)-1,3-thiazole-5-carboxamide hydrochloride (Intermediate 81).
출처 및 근거
- ORD 기록
- ord-10881ef819ec41d98e32b9688e370ee6
- 출처 데이터셋
- uspto-grants-2010_05
- 특허 번호
- US07709503B2
반응 노트
불러오는 중…